Insights & News / Mayer Winkler

Itay Gura, Mayer Winkler, and Inbar Katzir represented both T-Rex Group and Finsight in the sale of all the assets of T-Rex, a pioneering startup specializing in private credit, to Finsight, an American fintech company.

Simon Jaffa, Yuval Lazi, Mayer Winkler, Tal Freilich, Nofar Rose David, and Dana Ben Yehuda from our firm's Corporate Department represented UK-based investment management firm One Peak Partners in its investment in Coro, an Israeli cybersecurity startup.

We represented Azrieli Group in the acquisition of a London data center operator for GBP 52 million. The acquisition is part of Azrieli's expansion in the data center sector. Ariella Dreyfuss, Mayer Winkler, and Tal Freilich provided representation in the transaction.

Shift4 Payments, an American public company, has acquired Finaro for a value of USD 575 million.

Advs. Simon Jaffa, Ariella Dreyfuss, Mayer Winkler, Harel Perlmutter, Hanna Daher, and Fadi Atallah advised on the transaction.

Our firm is representing Ness Technologies, owned by Hilan, a TASE-traded software company, in a transaction to acquire 100% of the share capital of DXC Technology's IT services company in Israel (formerly EDS). The scope of the transaction is USD 65 million, and its completion is expected at the end of the first quarter of 2022. Advs. Micky Barnea, Yuval Lazi, Mayer Winkler, and Dana Ben-Yehuda represent Ness in the transaction.

Firm partner Yuval Lazi and associate Mayer Winkler advised Gnrgy, a company operating in the field of electric vehicle charging, in its sale to public company O.P.C. Energy, part of the Idan Ofer Group. The transaction amount was NIS 67 million. Our legal services consisted of advising on all aspects of the transaction, including antitrust issues.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

Barnea represented Motive Partners, a US-based private equity fund, and LPA, its German daughter company, in the acquisition of Israeli fintech company Modelity Ltd. Advs. Yuval Lazi, Uri Hillel, and Mayer Winkler represented the buyer.

Our firm is representing the Chinese investment fund Neng Yang in its acquisition of Advanced Dicing Technologies Ltd. (ADT). ADT is an Israel-based electronics dicing equipment company. The acquisition amount is USD 35 million.

Our firm represented the private equity group Bridgepoint in the acquisition of control in the Israeli software testing company Qualitest from Marlin Equity Partners for approx. USD 420 million.

Our firm represented Axcel in the acquisition of Phase One from Silverfleet Capital. Axcel is a leading Nordic private equity firm focusing on mid-market companies. It has a broad base of both Nordic and international investors.

Micky Barnea, Ariella Dreyfuss, Itay Gura and Mayer Winkler represented Johnson & Johnson Innovation in an investment round in the Israeli medtech startup Techsomed Medical Technologies Ltd. Founded in 2012, Techsomed has developed an image analysis system that helps track tissue response to thermal ablation, the process of destroying tumors using extreme heat or cold. Techsomed intends to use the funding toward receiving regulatory approval in the US, Europe, and Japan.

JJDC led the company's current round of financing, which included both former and new investors, such as Screen Holdings, the Alfred Mann Institute at the Technion (AMIT), NextLeap Ventures, and Axil Capital.

Our firm represented the Singapore-based venture capital fund VisVires New Protein (VVNP) in an investment round in Aleph Farms, an Israeli food-tech startup.

Advs. Michael Barnea and Mayer Winkler co-authored the chapter on foreign investment in Israel in the Legal 500 guide, providing information on the key factors to consider when looking to invest in Israeli companies by way of M&A.

Our firm represented the US pharmaceutical and medical devices company Johnson & Johnson Development Corporation (JJDC) in a USD 3 million lead investment round in OrthoSpin Ltd. OrthoSpin is an Israeli-based startup that provides smart robotic external fixation systems.

Barnea represented ADM Capital, a UK-based investment fund, in an investment round in the Israeli plant-breeding startup Rootility.

Barnea represented Johnson & Johnson in respect of its investment of USD 12 million in the startup, DayTwo, which provides personalized nutrition recommendations based on mapping and analyzing the composition of intestinal bacteria.

Barnea represented Israel Growth Partners (IGP)  in an agreement to buy 300,000 Jacada shares, 7% of the company's share capital, from Robert (Bob) Ashton's investment firm Kinetic Catalyst Partners.

V-Wave, a privately held company with offices in Israel and the U.S., completed a Series B financing round in the sum of $28m.

The round was led by Johnson & Johnson Innovation - JJDC Inc. (represented by Barnea). Other participants were TriVentures, Pura Vida and BioStar Ventures. Eli and Nir Barkat's BRM fund, Pontifax and Edwards Lifesciences, which were already shareholders in V-Wave, also participated.

The firm welcomes Adv. Ezra Katzen , a new partner in the technology department, Adv.  Daniel Lorber and Adv.  Mayer Winkler that will work in the firm’s commercial department.